"Nanordica Medical Raises €1.75M to Develop Advanced Antibacterial Products and Expand Operations"

Nanordica Medical's Funding Round

Key Highlights:

• Funding Round: Nanordica Medical, a healthtech startup developing advanced antibacterial products, raised €1.75 million in funding.
• Investors: Specialist VC led the round, with participation from Superangel and Amalfi.
• Product Development: The funding will be used to expand operations and continue the development of Nanordica Medical's advanced antibacterial products.

Nanordica Medical's Target Market

• Healthcare Providers: Hospitals, clinics, and healthcare facilities in need of advanced antibacterial products for wound care and infection prevention.
• Medical Device Manufacturers: Companies looking to incorporate nanotechnology-based antibacterial solutions into their product offerings.
• Research Institutions: Organizations involved in medical research and development, particularly in the field of antibacterial technologies.

What Nanordica Medical Needs to Buy

• Manufacturing Equipment and Supplies: Investments in manufacturing equipment and supplies to scale up production of antibacterial products.
• Research and Development Partnerships: Collaborations with research institutions and experts to further enhance and expand the applications of their nanotechnology.
• Marketing and Sales Support: Services to help promote and distribute their antibacterial products to healthcare providers and medical device manufacturers.